CHINA PHARMA HOLDINGS, INC. Income Taxes Paid
CHINA PHARMA HOLDINGS, INC. (CPHI) reported Income Taxes Paid of $0 for the 9-month period ending 2015-09-30, per its 10-Q filed 2015-12-28.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaidNet · last filed 2015-12-28
- CHINA PHARMA HOLDINGS, INC. income taxes paid, net for the quarter ending 2015-09-30 was $0.00.
- CHINA PHARMA HOLDINGS, INC. income taxes paid, net for the quarter ending 2015-06-30 was $0.00.
- CHINA PHARMA HOLDINGS, INC. income taxes paid, net for the quarter ending 2015-03-31 was $0.00.
- CHINA PHARMA HOLDINGS, INC. income taxes paid, net for the quarter ending 2014-12-31 was $0.00, a 100.00% decline year-over-year.
- CHINA PHARMA HOLDINGS, INC. income taxes paid, net for fiscal 2014 was $0.00, a 100.00% decline from fiscal 2013.
- CHINA PHARMA HOLDINGS, INC. income taxes paid, net for fiscal 2013 was $2.48M, a 16.00% increase from fiscal 2012.
- CHINA PHARMA HOLDINGS, INC. income taxes paid, net for fiscal 2012 was $2.14M, a 52.81% decline from fiscal 2011.
- CHINA PHARMA HOLDINGS, INC. income taxes paid, net for fiscal 2011 was $4.53M, a 59.62% increase from fiscal 2010.
| Period end | Income Taxes Paid, Net 3 month | Income Taxes Paid, Net 3 month as first filed | Income Taxes Paid, Net 6 month | Income Taxes Paid, Net 9 month | Income Taxes Paid, Net 12 month |
|---|---|---|---|---|---|
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-12-28 | $0.00 derived: sum of 2 quarters · filed 2015-12-28 | $0.00 10-Q · filed 2015-12-28 | $0.00 derived: sum of 4 quarters · filed 2015-12-28 | |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-12-28 | $0.00 10-Q · filed 2015-12-28 | $0.00 derived: sum of 3 quarters · filed 2015-12-28 | $0.00 derived: sum of 4 quarters · filed 2015-12-28 | |
| 2015-03-31 | $0.00 10-Q · filed 2015-12-28 | $0.00 derived: sum of 2 quarters · filed 2015-12-28 | $0.00 derived: sum of 3 quarters · filed 2015-12-28 | $0.00 derived: sum of 4 quarters · filed 2015-12-28 | |
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-12-28 | $0.00 derived: sum of 2 quarters · filed 2015-12-28 | $0.00 derived: sum of 3 quarters · filed 2015-12-28 | $0.00 10-K · filed 2015-12-28 | |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-12-28 | $0.00 derived: sum of 2 quarters · filed 2015-12-28 | $0.00 10-Q · filed 2015-12-28 | $9.06K derived: sum of 4 quarters · filed 2015-12-28 | |
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-12-28 | $0.00 10-Q · filed 2015-12-28 | $9.06K derived: sum of 3 quarters · filed 2015-12-28 | $765.10K derived: sum of 4 quarters · filed 2015-12-28 | |
| 2014-03-31 | $0.00 10-Q · filed 2015-12-28 | $9.06K derived: sum of 2 quarters · filed 2015-12-28 | $765.10K derived: sum of 3 quarters · filed 2015-12-28 | $2.48M derived: sum of 4 quarters · filed 2015-12-28 | |
| 2013-12-31 | $9.06K derived: 10-K 12 month − 10-Q 9 month · filed 2015-12-28 | $765.10K derived: sum of 2 quarters · filed 2015-12-28 | $2.48M derived: sum of 3 quarters · filed 2015-12-28 | $2.48M 10-K · filed 2015-12-28 | |
| 2013-09-30 | $756.03K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | $2.47M derived: sum of 2 quarters · filed 2014-11-14 | $2.47M 10-Q · filed 2014-11-14 | $3.27M derived: sum of 4 quarters · filed 2014-11-14 | |
| 2013-06-30 | $1.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | $1.72M 10-Q · filed 2014-08-14 | $2.51M derived: sum of 3 quarters · filed 2014-08-14 | $3.27M derived: sum of 4 quarters · filed 2014-08-14 | |
| 2013-03-31 | $507.00 10-Q · filed 2014-05-15 | $1.59M 10-Q · filed 2013-05-14 | $795.40K derived: sum of 2 quarters · filed 2014-05-15 | $1.55M derived: sum of 3 quarters · filed 2014-05-15 | $1.86M derived: sum of 4 quarters · filed 2014-05-15 |
| 2012-12-31 | $794.90K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-20 | $1.55M derived: sum of 2 quarters · filed 2014-03-20 | $1.86M derived: sum of 3 quarters · filed 2014-03-20 | $2.14M 10-K · filed 2014-03-20 | |
| 2012-09-30 | $755.30K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | $1.07M derived: sum of 2 quarters · filed 2013-11-14 | $1.34M 10-Q · filed 2013-11-14 | $4.32M derived: sum of 4 quarters · filed 2013-11-14 | |
| 2012-06-30 | $314.07K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | $588.66K 10-Q · filed 2013-08-14 | $3.57M derived: sum of 3 quarters · filed 2013-08-14 | $4.50M derived: sum of 4 quarters · filed 2013-08-14 | |
| 2012-03-31 | $274.59K 10-Q · filed 2013-05-14 | $3.25M derived: sum of 2 quarters · filed 2013-05-14 | $4.19M derived: sum of 3 quarters · filed 2013-05-14 | $4.42M derived: sum of 4 quarters · filed 2013-05-14 | |
| 2011-12-31 | $2.98M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-14 | $3.92M derived: sum of 2 quarters · filed 2013-03-14 | $4.15M derived: sum of 3 quarters · filed 2013-03-14 | $4.53M 10-K · filed 2013-03-14 | |
| 2011-09-30 | $936.79K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14 | $1.17M derived: sum of 2 quarters · filed 2012-11-14 | $1.55M 10-Q · filed 2012-11-14 | $2.50M derived: sum of 4 quarters · filed 2012-11-14 | |
| 2011-06-30 | $232.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14 | $617.54K 10-Q · filed 2012-08-14 | $1.57M derived: sum of 3 quarters · filed 2012-08-14 | $550.92K derived: sum of 4 quarters · filed 2012-08-14 | |
| 2011-03-31 | $385.55K 10-Q · filed 2012-05-14 | $1.34M derived: sum of 2 quarters · filed 2012-05-14 | $318.93K derived: sum of 3 quarters · filed 2012-05-14 | ||
| 2010-12-31 | $949.74K derived: 10-K 12 month − 10-Q/A 9 month · filed 2012-03-14 | -$66.62K derived: sum of 2 quarters · filed 2012-03-14 | $2.84M 10-K · filed 2012-03-14 | ||
| 2010-09-30 | -$1.02M derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2012-03-06 | $1.89M 10-Q/A · filed 2012-03-06 | |||
| 2010-06-30 | $2.91M 10-Q/A · filed 2011-09-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |